What is it about?

Dapagliflozin ,and antidiabetic drug can also influence the central cardiovascular system ,maybe a critical link in its effect to reduce heart failure in patients with diabetes.

Featured Image

Why is it important?

More and more clinical guideline suggest the SGLT-2i be used in the pateints with diabetes who have risks of developing heart failure .However,its effects are to be determined.

Perspectives

In the future, central cardiovascular control may become more and more critical in the management of diabetes especially with cardiovascular risks.

Dr. Song Wen
Shanghai Pudong Hospital

In future ,central cardiovascular control may become more and more critical in the management of diabetes especially with cardiovascular risks.

Nguyen Thiquynhnga
Shanghai Pudong Hospital

Read the Original

This page is a summary of: Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice, Diabetes Metabolic Syndrome and Obesity Targets and Therapy, August 2020, Taylor & Francis, DOI: 10.2147/dmso.s258593.
You can read the full text:

Read

Contributors

The following have contributed to this page